Reider Paul 4
4 · Coherus BioSciences, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Reider Paul
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2025-01-04$1.66/sh−2,277$3,780→ 86,927 total - Award
Stock Option (Right to Buy)
2025-01-03+160,000→ 160,000 totalExercise: $1.66Exp: 2035-01-03→ Common Stock (160,000 underlying)
Footnotes (2)
- [F1]Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.
- [F2]The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.